{"transactions":[{"id":789957,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":49376,"kind":"person","name":"Rajavelu Esther","position":1,"cik":"0001903716","reported_name":"Rajavelu Esther","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-07T01:53:26.000Z","date":"2026-05-04","kind":"sale","planned":false,"acquired":false,"shares":25240,"price":2.51,"value":63352.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":986851,"source":{"system":"sec-edgar","filing":"0001193125-26-209884","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312526209884/ownership.xml","form_type":"4"}},{"id":914491,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":49376,"kind":"person","name":"Rajavelu Esther","position":1,"cik":"0001903716","reported_name":"Rajavelu Esther","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-10T02:31:37.000Z","date":"2026-02-06","kind":"sale","planned":false,"acquired":false,"shares":50816,"price":2.36,"value":119925.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":1012091,"source":{"system":"sec-edgar","filing":"0001193125-26-043336","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312526043336/ownership.xml","form_type":"4"}},{"id":914490,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":49376,"kind":"person","name":"Rajavelu Esther","position":1,"cik":"0001903716","reported_name":"Rajavelu Esther","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-10T02:31:37.000Z","date":"2026-02-06","kind":"sale","planned":false,"acquired":false,"shares":37101,"price":2.36,"value":87558.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":1062907,"source":{"system":"sec-edgar","filing":"0001193125-26-043336","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312526043336/ownership.xml","form_type":"4"}},{"id":919435,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":49376,"kind":"person","name":"Rajavelu Esther","position":1,"cik":"0001903716","reported_name":"Rajavelu Esther","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-05T02:44:22.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":498000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest as to 25% on February 2, 2027, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":498000,"derivative":{"exercise_price":2.23,"expiration_date":"2036-02-02","underlying":"Common Stock","underlying_shares":498000},"source":{"system":"sec-edgar","filing":"0001193125-26-038184","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312526038184/ownership.xml","form_type":"4"}},{"id":919434,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":49376,"kind":"person","name":"Rajavelu Esther","position":1,"cik":"0001903716","reported_name":"Rajavelu Esther","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-05T02:44:22.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":18442,"price":2.2,"value":40572.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":1100008,"source":{"system":"sec-edgar","filing":"0001193125-26-038184","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312526038184/ownership.xml","form_type":"4"}},{"id":919433,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":49376,"kind":"person","name":"Rajavelu Esther","position":1,"cik":"0001903716","reported_name":"Rajavelu Esther","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-05T02:44:22.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":249000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\") granted to Reporting Person under Issuer's 2017 Stock Incentive Plan. Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in four equal annual installments beginning on February 2, 2027, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":1118450,"source":{"system":"sec-edgar","filing":"0001193125-26-038184","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312526038184/ownership.xml","form_type":"4"}},{"id":1002050,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":49376,"kind":"person","name":"Rajavelu Esther","position":1,"cik":"0001903716","reported_name":"Rajavelu Esther","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-13T01:44:50.000Z","date":"2025-11-07","kind":"sale","planned":false,"acquired":false,"shares":40270,"price":2.37,"value":95439.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction is a sale of common stock effected to cover tax withholding obligations pursuant to a \"sell to cover\" provision included in each RSU Agreement in connection with the vesting of restricted stock units (\"RSUs\") that were granted to the Reporting Person on November 13, 2023."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction is a sale of common stock effected to cover tax withholding obligations pursuant to a \"sell to cover\" provision included in each RSU Agreement in connection with the vesting of restricted stock units (\"RSUs\") that were granted to the Reporting Person on November 13, 2023."}],"balance_after":869450,"source":{"system":"sec-edgar","filing":"0001193125-25-278370","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312525278370/ownership.xml","form_type":"4"}},{"id":1157417,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":49376,"kind":"person","name":"Rajavelu Esther","position":1,"cik":"0001903716","reported_name":"Rajavelu Esther","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-05-07T00:01:37.000Z","date":"2025-05-02","kind":"grant","planned":false,"acquired":true,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in four equal annual installments beginning on May 2, 2026, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":909720,"source":{"system":"sec-edgar","filing":"0000950170-25-064821","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000095017025064821/ownership.xml","form_type":"4"}},{"id":1281886,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":49376,"kind":"person","name":"Rajavelu Esther","position":1,"cik":"0001903716","reported_name":"Rajavelu Esther","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CBO"}}],"security":"Common Stock","published_at":"2025-02-06T01:52:39.000Z","date":"2025-02-05","kind":"sale","planned":false,"acquired":false,"shares":20689,"price":0.78,"value":16137.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported transaction is a sale of common stock effected to cover tax withholding obligations pursuant to a \"sell to cover\" provision included in each RSU Agreement in connection with the vesting of RSUs that were granted to the Reporting Person on February 1, 2024."}],"balance_after":724720,"source":{"system":"sec-edgar","filing":"0000950170-25-014859","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000095017025014859/ownership.xml","form_type":"4"}},{"id":1281885,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":49376,"kind":"person","name":"Rajavelu Esther","position":1,"cik":"0001903716","reported_name":"Rajavelu Esther","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CBO"}}],"security":"Common Stock","published_at":"2025-02-06T01:52:39.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Each RSU represents the right to receive one share of common stock upon vesting. The RSUs shall vest in full on February 3, 2026, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":745409,"source":{"system":"sec-edgar","filing":"0000950170-25-014859","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000095017025014859/ownership.xml","form_type":"4"}},{"id":1281884,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":49376,"kind":"person","name":"Rajavelu Esther","position":1,"cik":"0001903716","reported_name":"Rajavelu Esther","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CBO"}}],"security":"Common Stock","published_at":"2025-02-06T01:52:39.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":266139,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in four equal annual installments beginning on February 3, 2026, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":645409,"source":{"system":"sec-edgar","filing":"0000950170-25-014859","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000095017025014859/ownership.xml","form_type":"4"}},{"id":1369006,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":49376,"kind":"person","name":"Rajavelu Esther","position":1,"cik":"0001903716","reported_name":"Rajavelu Esther","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CBO"}}],"security":"Common Stock","published_at":"2024-11-12T21:05:10.000Z","date":"2024-11-08","kind":"sale","planned":false,"acquired":false,"shares":17245,"price":1.3,"value":22418.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction is a sale of common stock effected to cover tax withholding obligations pursuant to a \"sell to cover\" provision included in each RSU Agreement in connection with the vesting of RSUs that were granted to the Reporting Person on November 13, 2023."}],"balance_after":379270,"source":{"system":"sec-edgar","filing":"0000950170-24-125339","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000095017024125339/ownership.xml","form_type":"4"}},{"id":1369005,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":49376,"kind":"person","name":"Rajavelu Esther","position":1,"cik":"0001903716","reported_name":"Rajavelu Esther","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CBO"}}],"security":"Common Stock","published_at":"2024-11-12T21:05:10.000Z","date":"2024-11-07","kind":"sale","planned":false,"acquired":false,"shares":23351,"price":1.31,"value":30589.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction is a sale of common stock effected to cover tax withholding obligations pursuant to a \"sell to cover\" provision included in each RSU Agreement in connection with the vesting of RSUs that were granted to the Reporting Person on November 13, 2023."}],"balance_after":396515,"source":{"system":"sec-edgar","filing":"0000950170-24-125339","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000095017024125339/ownership.xml","form_type":"4"}},{"id":1658954,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":49376,"kind":"person","name":"Rajavelu Esther","position":1,"cik":"0001903716","reported_name":"Rajavelu Esther","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-06T01:44:28.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":119866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in four equal annual installments beginning on February 1, 2025, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":419866,"source":{"system":"sec-edgar","filing":"0000950170-24-011490","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000095017024011490/ownership.xml","form_type":"4"}},{"id":1740849,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":49376,"kind":"person","name":"Rajavelu Esther","position":1,"cik":"0001903716","reported_name":"Rajavelu Esther","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-11-15T21:17:15.000Z","date":"2023-11-13","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in four equal annual installments beginning on November 6, 2024, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0000950170-23-064189","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000095017023064189/ownership.xml","form_type":"4"}},{"id":2019357,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":49376,"kind":"person","name":"Rajavelu Esther","position":1,"cik":"0001903716","reported_name":"Rajavelu Esther","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-13T21:15:14.000Z","date":"2023-02-09","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 9, 2023 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2023, subject to the reporting person's continued service on each such vesting date."}],"balance_after":160000,"derivative":{"exercise_price":12.59,"expiration_date":"2033-02-08","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0000899243-23-004742","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924323004742/doc4.xml","form_type":"4"}},{"id":2438639,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":49376,"kind":"person","name":"Rajavelu Esther","position":1,"cik":"0001903716","reported_name":"Rajavelu Esther","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-10T21:30:41.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 3, 2022 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of January 3, 2022. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service."}],"balance_after":200000,"derivative":{"exercise_price":17.82,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000899243-22-001475","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924322001475/doc4.xml","form_type":"4"}}]}